These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14632590)

  • 21. Epidemiology, comparative methods of detection, and preventability of adverse drug events.
    Al-Tajir GK; Kelly WN
    Ann Pharmacother; 2005; 39(7-8):1169-74. PubMed ID: 15928265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects associated with herbal medicine.
    Pinn G
    Aust Fam Physician; 2001 Nov; 30(11):1070-5. PubMed ID: 11759460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
    Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
    Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.
    Talat B; Mayers A; Baldwin DS
    Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between computerized physician order entry and pediatric adverse drug events: a nested matched case-control study.
    Yu F; Salas M; Kim YI; Menachemi N
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):751-5. PubMed ID: 19479715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugs.
    Belknap SM; Georgopoulos CH; West DP; Yarnold PR; Kelly WN
    Clin Pharmacol Ther; 2010 Aug; 88(2):231-6. PubMed ID: 20571489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential risks and prevention, Part 1: Fatal adverse drug events.
    Kelly WN
    Am J Health Syst Pharm; 2001 Jul; 58(14):1317-24. PubMed ID: 11471479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.
    de Vries ST; Mol PG; de Zeeuw D; Haaijer-Ruskamp FM; Denig P
    Drug Saf; 2013 Sep; 36(9):765-77. PubMed ID: 23553447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for submitting adverse event reports for publication.
    Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards IR; Fernandez AM; Freedman SB; Goldsmith DI; Huang K; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):581-7. PubMed ID: 17471601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of Adverse Drug Events-Scorecards.
    Marcilly R; Chazard E; Beuscart-Zéphir MC; Hackl W; Băceanu A; Kushniruk A; Borycki EM
    Stud Health Technol Inform; 2011; 164():377-81. PubMed ID: 21335740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.
    de Vries ST; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
    Health Qual Life Outcomes; 2014 Aug; 12():103. PubMed ID: 25115618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China.
    He W; Yao D; Hu Y; Dai H
    Ther Clin Risk Manag; 2018; 14():2139-2147. PubMed ID: 30464487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of adverse drug event information in US manufacturer labels.
    Harrington CA; Garcia AS; Sircar-Ramsewak F
    Curr Drug Saf; 2011 Feb; 6(1):30-5. PubMed ID: 21047299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bradford Hill criteria and zinc-induced anosmia: a causality analysis.
    Davidson TM; Smith WM
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):673-6. PubMed ID: 20644061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Algorithms used in adverse drug event reports: a comparative study.
    Frick PA; Cohen LG; Rovers JP
    Ann Pharmacother; 1997 Feb; 31(2):164-7. PubMed ID: 9034415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case reports of adverse effects of herbal medicinal products (HMPs): a quality assessment.
    Hung SK; Hillier S; Ernst E
    Phytomedicine; 2011 Mar; 18(5):335-43. PubMed ID: 20739165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for submitting adverse event reports for publication.
    Kelly W; Arellano F; Barnes J; Bergman U; Edwards R; Fernandez A; Freedman S; Goldsmith D; Huang K; Jones J; McLeay R; Moore N; Stather R; Trenque T; Troutman W; van Puijenbroek E; Williams F; Wise R; ;
    Therapie; 2009; 64(4):289-94. PubMed ID: 19804709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of physicians' attitudes on reporting adverse drug events: a case-control study.
    Figueiras A; Tato F; Fontaiñas J; Gestal-Otero JJ
    Med Care; 1999 Aug; 37(8):809-14. PubMed ID: 10448723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for submitting adverse event reports for publication.
    Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards RI; Fernandez AM; Freedman SB; Goldsmith DI; Huang KA; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
    Drug Saf; 2007; 30(5):367-73. PubMed ID: 17472416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
    Loke YK; Price D; Derry S; Aronson JK
    BMJ; 2006 Feb; 332(7537):335-9. PubMed ID: 16421149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.